Allie Karas

SVP of Content @MJHLifeSciences

[MJH Life Sciences® @MJHLifeSciences]

Not All Heroes Wear Capes — Some Wear Scrubs. 🦸‍♂️🩺 Thank you to all our healthcare heroes for your incredible strength, compassion, and dedication. #SuperheroDay #HealthcareHeroes #MJHLifeSciences #SPIRIT #MJHTeam

[HCPLive @HCPLiveNews]

🚨BREAKING🚨

The #FDA has approved bimekizumab (#Bimzelx) for the treatment of adults of moderate to severe hidradenitis suppurativa, also known as #HS.

Want to learn more?

View our summary here 👇
https://t.co/ZU6YyPDPKy

[HCPLive @HCPLiveNews]

BREAKING: The #FDA has approved the first ever biologic medicine for treatment of COPD.

The drug is dupilumab, also known as Dupixent.

Find out more here 👇
https://t.co/qyrVtQqt8a

[Dermatology Times @DermTimesNow]

We've arrived at Maui Derm NP+PA Fall in Nashville! #MauiDermFall2024

Stick with us here on social media and sign up to receive daily highlights, including session recaps, expert interviews, and more: https://t.co/OXKoMQlKDz

[Contagion @Contagion_Live]

#LongCOVID's impact on the brain goes beyond lingering concerns, it is a pressing health challenge.

Expert insights, recent studies, and research from @neurology_live reveal symptoms can persist long after the initial infection.

https://t.co/BeNPAiOuaQ

[Allie Karas @alliewardkaras]

SO excited to finally announce the launch of @TheEduPatient! We have always prided ourselves on keeping clinicians up-to-date on news in their specialty and now we have built a resource to arm patients with the same knowledge.

https://t.co/NIjQj72pAL

[Dermatology Times @DermTimesNow]

🚨 Regeneron Pharmaceuticals, Inc. and Sanofi announced today that the phase 3 LIBERTY-CUPID Study C trial for #dupilumab (Dupixent) in #chronicspontaneousurticaria met its primary and secondary endpoints. #dermtwitter

https://t.co/xu2SJ8yn0C

[Contagion @Contagion_Live]

The African #mpox outbreak has escalated dramatically as the #Africa #CDC declares the virus a Public Health Emergency of Continental Security.

https://t.co/6JjxLM0RZh

[CGTLive® @CGT_Live]

Last month saw announcements regarding the @US_FDA's START Pilot Program and Center for Biologics Evaluation and Research (@FDACBER)'s Interactive Site Tours Program.

#celltherapy #genetherapy

Read more:

https://t.co/ZZgv7h3b0M

[NeurologyLive® @neurology_live]

#BREAKING: The @US_FDA has approved @alpha_cognition’s ALPHA-1062 (Zunveyl), a prodrug of an approved acetylcholinesterase inhibitor, galantamine, as a treatment for patients with mild-to-moderate #AlzheimerDisease.

https://t.co/g2HKws6Sdo

[Contagion @Contagion_Live]

We launched our new online edition of Contagion. We have the same clinical content, with a little more in terms of freshening up the issue and adding more in the way of graphics, videos, and other elements. #IDtwitter #MedTwitter
Read it here:
https://t.co/4E8sSU1KVy

[HCPLive @HCPLiveNews]

Did you know the FDA approved 20 novel drugs in the first half of 2024?

Check out first half recap to learn more about these new agents and how they might impact care: https://t.co/VTZ9isOYhp

[CGTLive® @CGT_Live]

Despite the potential of gene therapy for PD, substantial challenges impede its translation into clinical practice.

#ParkinsonsDisease #Parkinsons #genetherapy #celltherapy

Read more:

https://t.co/fQckg7nES7

[HCPLive @HCPLiveNews]

“One challenge in trauma treatment is the therapeutic processing of traumatic memories can only happen when a patient feels safe. But many patients with #PTSD move through the world feeling fundamentally unsafe."

#FDA committee meeting update for #MDMA:

https://t.co/NITrFDhjdA

[HCPLive @HCPLiveNews]

🚨Mark your calendars! 🚨
On June 04 at 6 PM EST, we will be hosting a YouTube livestream with Dr. Franklin King, a board-certified psychiatrist, immediately following the FDA's PDAC on @Lykos_PBC MDMA capsules in the treatment of #PTSD.
https://t.co/gp4XYPUCNQ
#Psychiatry

[Contagion @Contagion_Live]

Lyme Disease Awareness Month: advocate, research, educate, prevent.
Gain insights from Dr. Kiersten Kugeler and Dr. Elitza Theel on combating Lyme disease and promoting healthier communities nationwide. #LymeDiseaseAwareness https://t.co/856WmScRhH

[Contemporary OB/GYN® @ContempOBGYN]

We are onsite at the 2024 @acog Annual Clinical and Scientific Meeting here in San Francisco! Check our website and feed frequently throughout the weekend for the latest clinical updates in obstetrics and gynecology and insights from the leading specialty experts.

[CGTLive® @CGT_Live]

#BREAKING: The FDA has approved fidanacogene elaparvovec-dzkt (Beqvez; @pfizer) for the treatment of adults with moderate to severe hemophilia B.

#HemophiliaB #Hemophilia #genetherapy

Read more:

https://t.co/VF0AnQonu7

[dvm360® @dvm360]

A novel therapy for treating fear and anxiety in felines has been commercially launched https://t.co/e6tLunwwCI